SL
AGN

Savior LLC’s Allergan plc AGN Stock Holding History

Savior LLC’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-216
Closed -$38K – 891
2020
Q1 		$38K Hold
216
– – 0.04% 138
2019
Q4 		$41K Buy
+216
New +$39K 0.05% 179

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Savior LLC's AGN Position: Q2 2020 in Review

Savior LLC sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 216 shares — an estimated $38K sold.

Savior LLC first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $41K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Savior LLC reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Savior LLC sold 216 Allergan plc shares in Q2 2020, an estimated $38K.
  • Savior LLC first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Savior LLC's Allergan plc position peaked at $41K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Savior LLC's 13F filing for Q2 2020, filed 28 Jul 2020.